• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碘定量与 FDG 摄取在非小细胞肺癌早期治疗反应评估中的相关性:双能 CT 扫描作为 PET/CT 检查的一个组成部分可能具有获益。

Correlation of Iodine Quantification and FDG Uptake in Early Therapy Response Assessment of Non-small Cell Lung Cancer: Possible Benefit of Dual-energy CT Scan as an Integral Part of PET/CT Examination.

机构信息

Department of Imaging Methods, Faculty of Medicine in Pilsen, Charles University and University Hospital in Pilsen, Pilsen, Czech Republic

Department of Imaging Methods, Faculty of Medicine in Pilsen, Charles University and University Hospital in Pilsen, Pilsen, Czech Republic.

出版信息

Anticancer Res. 2020 Jun;40(6):3459-3468. doi: 10.21873/anticanres.14332.

DOI:10.21873/anticanres.14332
PMID:32487645
Abstract

AIM

To compare iodine-related and fluorine-18 fluorodeoxyglucose (F-FDG) parameters during staging of lung cancer as well as during early follow-up, while investigating potential use and possible substitutability in the assessment of therapeutic response or prediction.

PATIENTS AND METHODS

Patients (n=45) with confirmed lung cancer underwent F-FDG positron-emission tomography (PET) using single-source dual-energy computed tomography was performed for staging and early follow-up. Correlation of FDG uptake and iodine-related parameters was assessed and comparison with therapy response was performed.

RESULTS

A strong correlation was found between the volumetric FDG parameters metabolic tumour volume (MTV) and total lesion glycolysis (TLG) and iodine uptake (IU) in staging (IU vs. MTV: r=0.894; p<0.001 and IU vs. TLG: r=0.874; p<0.001) and follow-up (IU vs. MTV: r=0.934, p<0.001 and IU vs. TLG: r=0.935, p<0.001). We also found significant correlation of change in these values between timepoints. We observed a significant correlation of IU, MTV and TLG with early therapy response and IU was found as a possible strong predictor.

CONCLUSION

Strong correlation of IU and volume-based FDG parameters was proved in staging, follow-up and change during therapy. Potential role of IU in prediction of early therapy-response was identified. Our study suggests a significant benefit of using the dual-energy computed tomography as a part of F-FDG PET/CT in patients with lung cancer.

摘要

目的

比较肺癌分期和早期随访期间碘相关参数和氟-18 氟代脱氧葡萄糖(F-FDG)的参数,同时研究其在评估治疗反应或预测中的潜在用途和可能的替代性。

患者和方法

经证实患有肺癌的患者(n=45)接受了 F-FDG 正电子发射断层扫描(PET),使用单源双能计算机断层扫描进行分期和早期随访。评估 FDG 摄取与碘相关参数的相关性,并与治疗反应进行比较。

结果

在分期(IU 与 MTV:r=0.894;p<0.001 和 IU 与 TLG:r=0.874;p<0.001)和随访(IU 与 MTV:r=0.934,p<0.001 和 IU 与 TLG:r=0.935,p<0.001)中,发现体积 FDG 参数代谢肿瘤体积(MTV)和总病变糖酵解(TLG)与碘摄取(IU)之间存在很强的相关性。我们还发现这些值在时间点之间的变化存在显著相关性。我们观察到 IU、MTV 和 TLG 与早期治疗反应显著相关,IU 被认为是一个可能的强预测因子。

结论

在分期、随访和治疗过程中,IU 与基于体积的 FDG 参数之间存在很强的相关性。在预测早期治疗反应方面,IU 具有潜在的作用。我们的研究表明,在肺癌患者中,使用双能计算机断层扫描作为 F-FDG PET/CT 的一部分具有显著的益处。

相似文献

1
Correlation of Iodine Quantification and FDG Uptake in Early Therapy Response Assessment of Non-small Cell Lung Cancer: Possible Benefit of Dual-energy CT Scan as an Integral Part of PET/CT Examination.碘定量与 FDG 摄取在非小细胞肺癌早期治疗反应评估中的相关性:双能 CT 扫描作为 PET/CT 检查的一个组成部分可能具有获益。
Anticancer Res. 2020 Jun;40(6):3459-3468. doi: 10.21873/anticanres.14332.
2
Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.基于双能计算机断层扫描的碘定量用于评估肺癌对放化疗/放疗的反应:与基于氟-18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的实体瘤正电子发射断层扫描/计算机断层扫描反应评估标准的比较
J Comput Assist Tomogr. 2018 Jul/Aug;42(4):614-622. doi: 10.1097/RCT.0000000000000734.
3
Single-source Dual-energy CT as a Part of F-FDG PET/CT: Direct Comparison of Iodine-related and Metabolic Parameters in Non-small Cell Lung Cancer.单源双能量CT作为F-FDG PET/CT的一部分:非小细胞肺癌中碘相关参数与代谢参数的直接比较
Anticancer Res. 2018 Jul;38(7):4131-4137. doi: 10.21873/anticanres.12704.
4
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.(18)F-FDG PET 代谢肿瘤负荷对非小细胞肺癌手术患者的预后价值。
Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.
5
Prognostic Value of the Volumetric Parameters of Dual-Time-Point F-FDG PET/CT in Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy.双时相 F-FDG PET/CT 容积参数对接受根治性放疗的非小细胞肺癌的预后价值。
AJR Am J Roentgenol. 2019 Dec;213(6):1366-1373. doi: 10.2214/AJR.19.21376. Epub 2019 Sep 11.
6
Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.治疗前 FDG PET/CT 全身总病变糖酵解对非小细胞肺癌的预后价值。
Radiology. 2012 Aug;264(2):559-66. doi: 10.1148/radiol.12111148. Epub 2012 Jun 12.
7
Consistency of metabolic tumor volume of non-small-cell lung cancer primary tumor measured using 18F-FDG PET/CT at two different tracer uptake times.在两个不同示踪剂摄取时间使用18F-FDG PET/CT测量的非小细胞肺癌原发肿瘤代谢肿瘤体积的一致性。
Nucl Med Commun. 2016 Jan;37(1):50-6. doi: 10.1097/MNM.0000000000000396.
8
18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response.新辅助化疗下非小细胞肺癌的18F-FDG PET/CT:基于背景的自适应体积指标在预测组织病理学反应方面优于总病变糖酵解(TLG)和代谢肿瘤体积(MTV)
J Nucl Med. 2016 Jun;57(6):849-54. doi: 10.2967/jnumed.115.167684. Epub 2016 Jan 28.
9
Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.采用 FDG PET/CT 测量的容积参数在接受立体定向体部放射治疗的 I 期 NSCLC 患者中的应用:预后价值。
Radiology. 2014 Jan;270(1):275-81. doi: 10.1148/radiol.13130652. Epub 2013 Oct 28.
10
Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.局部晚期非小细胞肺癌患者风险分层的 FDG PET/CT 最佳容积学参数:来自 ACRIN 6668/RTOG 0235 试验的结果。
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1969-1983. doi: 10.1007/s00259-017-3753-x. Epub 2017 Jul 8.

引用本文的文献

1
Combination of Circulating Tumour DNA and F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study.循环肿瘤 DNA 与 F-FDG PET/CT 联合用于晚期非小细胞肺癌患者治疗反应的精准监测:一项前瞻性研究。
Cancer Genomics Proteomics. 2022 Mar-Apr;19(2):270-281. doi: 10.21873/cgp.20319.
2
Improving radiation physics, tumor visualisation, and treatment quantification in radiotherapy with spectral or dual-energy CT.利用光谱或双能 CT 提高放射治疗中的放射物理学、肿瘤可视化和治疗量化。
J Appl Clin Med Phys. 2022 Jan;23(1):e13468. doi: 10.1002/acm2.13468. Epub 2021 Nov 7.